Skip to main content
Department of Pharmacology Department of Pharmacology
FACULTY PROFILE STYLESHEET: do not remove this block

JoAnn Trejo, Ph.D.
Professor of Pharmacology
Senior Assistant Vice Chancellor for Health Sciences Faculty Affairs

Research Interests

Our research is focused on cell signaling and how it controls vascular inflammation and cancer. We study the function of G protein-coupled receptors, specifically protease-activated receptors, the tumor suppressor alpha-arrestin ARRDC3 and ubiquitin-driven inflammatory signaling. We discovered that ubiquitination of a subset of GPCRs initiates p38 inflammatory signaling and endothelial dysfunction. A major challenge is to understand how this pathway is regulated. We also discovered a new GPCR lysosomal sorting pathway that is regulated by the adaptor proteins ALIX and alpha-arrestin ARRDC3 – this pathway is dysregulated in invasive cancer. Another challenge is to understand how and why GPCRs sort into the ALIX and ARRDC3- dependent lysosomal sorting pathway and the impact of the tumor suppressor ARRDC3 on GPCR signaling and cancer progression.

 

Selected Publications

L. Gonzalez Ramirez, L. B. Orduña-Castillo, C. Bardeleben, H. Qin, Y. Lin, C. A. Birch, I. Kufareva and J. Trejo. (2026). Signaling bias of the protease-activated receptor-1 is dictated by distinct GRK5 and b-arrestin-2 determinants. Cell Reports, March 24, 2026: 45 (3),117041;doi: 10.1016/j.celrep.2026.117041

Caplan, C. Bardeleben, K. Dhawan, R. Plawat, I. Kufareva and J. Trejo (2025). ARRDC3 tyrosine phosphorylation functions as a switch to control c-Src versus WWP2 interactions and distinct scaffolding functions. J. Biol. Chem. July; 301(7)110270. doi: 10.1016/j.jbc.2025.110270

 Cheng and J. Trejo (2023). An siRNA library screen identifies CYLD and USP34 as deubiquitinases that regulate GPCR-p38 MAPK signaling and distinct inflammatory responses. J. Biol. Chem, Oct 20, 299(12)105370 doi10.1016/j.jbc.2023.105370

 Molinar-Inglis, C. A. Birch, D. A. Nicholas, L. Orduña-Castillo M. Cisneros-Aguirre, A. Patwardhan, B. Chen,J. Grimsey, L. J. Coronel, H. Lin, P.K.G. Menzies, M. A. Lawson, H. H. Patel and J. Trejo (2021). aPC/PAR1confers endothelial anti-apoptotic activity via a discrete β-arrestin-2-mediated Sphk1-S1PR1-Akt signaling axis.Proc. Natl. Acad. Sci. USA. Dec 7, 118(49):e2106623118, DOI: 10.1073/pnas.2106623118

C.R. Rada, H. Mejia-Pena, N.J. Grimsey, I.C. Cordova, J. Olson, J. Wozniak, D. J. Gonzalez, V. Nizet and J. Trejo (2021). Heat shock protein 27 activity is linked to endothelial barrier recovery after proinflammatory GPCR- induced disruption. Sci. Signaling. Aug 31;14(698):eabc1044.

Y. Lin, J. M. Wozniak, N. J. Grimsey, S. Girada, A. Patwardhan, O. Molinar-Inglis, T.H. Smith, J.D. Lapek, D. J. Gonzalez and J. Trejo (2020). Phospho-proteomic analysis of protease-activated receptor-1 biased signaling reveals unique modulators of endothelial barrier function. Proc. Natl. Acad. Sci. USA, Mar 3;117(9):5039-5048.

A.K.S. Arakaki, W.-A. Pan, H. Wedegaertner, I. Roca-Mercado, L. Chinn, T. S. Gujral and J. Trejo (2021). Alpha-arrestin ARRDC3 tumor suppressor function is linked to GPCR-induced TAZ activation and breast cancer metastasis. J. Cell Sci. 134(8):jcs254888

 

Divisions

Cancer Biology
Cardiovascular & Metabolic Diseases

Programs

Signaling & Molecular Pharmacology

CONTACT

(858) 246-0150


jotrejo@health.ucsd.edu

Websites

UCSD Profile
Trejo Lab